Ondansetron HCL 4 MG tablet 500S
Ended Awarded Last action
- Contract number
- SPE2DR26FCT8W
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $31,358
Award facts
- Contract value 100% obligated
- $31,357.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $31,357.89 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 500 tablets of Ondansetron HCL 4 mg on December 9, 2025, with an ultimate completion date of December 10, 2025. This is a non-set-aside competitive award with performance to be executed at the contractor's facility in Conshohocken, Pennsylvania. Ondansetron is a widely-used antiemetic medication commonly prescribed to manage nausea and vomiting in military and veteran healthcare settings. The award represents a child delivery order issued under AmerisourceBergen's larger indefinite delivery contract vehicle with the DLA.
This delivery order is issued under AmerisourceBergen Drug Corp's comprehensive $999.999 billion Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which runs through December 2026 and serves as the primary pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, maintains an extensive portfolio of federal contract awards with the Defense Logistics Agency and serves critical medical supply chain functions for the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The competitive award reflects the contractor's demonstrated capability to meet federal procurement requirements for pharmaceutical products across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FCT8W?
SPE2DR26FCT8W was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 9, 2025.
How much is contract SPE2DR26FCT8W worth?
The government has obligated $31,358 on SPE2DR26FCT8W.
Is contract SPE2DR26FCT8W an order under another contract?
Yes. SPE2DR26FCT8W is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCT8W competed?
The extent of competition for SPE2DR26FCT8W was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award